MBP-PLP fusion protein-induced EAE in C57BL/6 mice

Journal of Neuroimmunology

Volumn 177, Issue 1-2, 2006, Pages 99-111

  Kuerten, Stefanie ^a,c   Lichtenegger, Felix S ^a   Faas, Susan ^b   Angelov, Doychin N ^c   Tary Lehmann, Magdalena ^a   Lehmann, Paul V ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALEXION PHARMACEUTICALS   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Autoimmunity; Cytokines; EAE MS; Neuroimmunology; T cells

Indexed keywords

HYBRID PROTEIN; MBP PLP FUSION PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENCEPHALOMYELITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC PREDISPOSITION TO DISEASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; RECOMBINANT FUSION PROTEINS;

EID: 33746569230     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.03.021     Document Type: Article

References (96)

1. Alvord E.C., Hruby S., Hughes K., Shaw C.M., and Kies M.W. Comparisons of organ-specific antigens of the central nervous system. Int. Arch. Allergy Appl. Immunol. 36 Suppl-92 (1969)
2. Anderson A.C., Nicholson L.B., Legge K.L., Turchin V., Zaghouani H., and Kuchroo V.K. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191 (2000) 761-770
3. Bernard C.C. Experimental autoimmune encephalomyelitis in mice: genetic control of susceptibility. J. Immunogenet. 3 (1976) 263-274
4. Burns F.R., Li X.B., Shen N., Offner H., Chou Y.K., Vandenbark A.A., and Heber-Katz E. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169 (1989) 27-39
5. Cresswell P. Cell biology. Cutting and pasting antigenic peptides. Science 304 (2004) 525-527
6. Cross A.H., Trotter J.L., and Lyons J. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112 (2001) 1-14
7. Deloire M.S., Touil T., Brochet B., Dousset V., Caille J.M., and Petry K.G. Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment. Mult. Scler. 10 (2004) 540-548
8. de Rosbo N.K., Kaye J.F., Eisenstein M., Mendel I., Hoeftberger R., Lassmann H., Milo R., and Ben Nun A. The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501. J. Immunol. 173 (2004) 1426-1435
9. Dittmer U., and Hasenkrug K.J. Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines. AIDS Res. Hum. Retrovir. 15 (1999) 785
10. Einstein E.R., Robertson D.M., Dicaprio J.M., and Moore W. The isolation from bovine spinal cord of a homogeneous protein with encephalitogenic activity. J. Neurochem. 9 (1962) 353-361
11. Elliott E.A., McFarland H.I., Nye S.H., Cofiell R., Wilson T.M., Wilkins J.A., Squinto S.P., Matis L.A., and Mueller J.P. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98 (1996) 1602-1612
12. Eugster H.P., Frei K., Bachmann R., Bluethmann H., Lassmann H., and Fontana A. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29 (1999) 626-632
13. Forsthuber T., Yip H.C., and Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science 271 (1996) 1728-1730
14. Freund J., Lipton M.M., and Morrison L.R. Demyelination in the guinea pig in chronic allergic encephalomyelitis produced by injecting guinea pig brain in oil emulsion containing a variant of Mycobacterium butyricum. Arch. Pathol. (Chic.) 50 (1950) 108-121
15. Fritz R.B., and Zhao M.L. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice. J. Neurosci. Res. 45 (1996) 471-474
16. Fritz R.B., Chou C.H., and McFarlin D.E. Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J. Immunol. 130 (1983) 191-194
17. Fritz R.B., Skeen M.J., Chou C.H., Garcia M., and Egorov I.K. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 134 (1985) 2328-2332
18. Gasser D.L., Goldner-Sauve A., and Hickey W.F. Genetic control of resistance to clinical EAE accompanied by histological symptoms. Immunogenetics 31 (1990) 377-382
19. Goverman J., and Brabb T. Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis. Lab. Anim. Sci. 46 (1996) 482-492
20. Goverman J., Perchellet A., and Huseby E.S. The role of CD8(+) T cells in multiple sclerosis and its animal models. Curr. Drug Targets. Inflamm. Allergy 4 (2005) 239-245
21. Hafler D.A., Slavik J.M., Anderson D.E., O'Connor K.C., De Jager P., and Baecher-Allan C. Multiple sclerosis. Immunol. Rev. 204 (2005) 208-231
22. Hashim G.A., Sharpe R.D., Carvalho E., and Stevens L.E. The development of experimental allergic encephalomyelitis with immunizing doses of myelin basic protein. Proc. Soc. Exp. Biol. Med. 149 (1975) 646-651
23. Heeger P.S., Forsthuber T., Shive C., Biekert E., Genain C., Hofstetter H.H., Karulin A., and Lehmann P.V. Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J. Immunol. 164 (2000) 5771-5781
24. Hjelmstrom P., Juedes A.E., Fjell J., and Ruddle N.H. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161 (1998) 4480-4483
25. Hofstetter H.H., Shive C.L., and Forsthuber T.G. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J. Immunol. 169 (2002) 117-125
26. Hofstetter H.H., Karulin A.Y., Forsthuber T.G., Ott P.A., Tary-Lehmann M., and Lehmann P.V. The cytokine signature of MOG-specific CD4 cells in EAE of C57BL/6 mice. J. Neuroimmunol. 170 1-2 (2005) 105-114
27. Hofstetter H.H., Targoni O.S., Karulin A.Y., Forsthuber T.G., Tary-Lehmann M., and Lehmann P.V. Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the central nervous system of mice undergoing experimental allergic encephalomyelitis?. J. Immunol. 174 (2005) 4598-4605
28. Holz A., Bielekova B., Martin R., and Oldstone M.B. Myelin-associated oligodendrocytic basic protein: identification of an encephalitogenic epitope and association with multiple sclerosis. J. Immunol. 164 (2000) 1103-1109
29. Huseby E.S., Sather B., Huseby P.G., and Goverman J. Age-dependent T cell tolerance and autoimmunity to myelin basic protein. Immunity 14 (2001) 471-481
30. Huseby E.S., Liggitt D., Brabb T., Schnabel B., Ohlen C., and Goverman J. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194 (2001) 669-676
31. Iglesias A., Bauer J., Litzenburger T., Schubart A., and Linington C. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 36 (2001) 220-234
32. Jahng A.W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., and Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194 (2001) 1789-1799
33. Jansson L., Diener P., Engstrom A., Olsson T., and Holmdahl R. Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice. Eur. J. Immunol. 25 (1995) 2195-2200
34. Jordan E.K., McFarland H.I., Lewis B.K., Tresser N., Gates M.A., Johnson M., Lenardo M., Matis L.A., McFarland H.F., and Frank J.A. Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset. AJNR Am. J. Neuroradiol. 20 (1999) 965-976
35. Kabat E.A., Wolf A., and Bezer A.E. Experimental studies on acute disseminated encephalomyelitis in rhesus monkeys. Res. Publ. - Assoc. Res. Nerv. Ment. Dis. 28 (1950) 113-132
36. Karulin A.Y., Hesse M.D., Tary-Lehmann M., and Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164 (2000) 1862-1872
37. Karulin A.Y., Hesse M.D., Yip H.C., and Lehmann P.V. Indirect IL-4 pathway in type 1 immunity. J. Immunol. 168 (2002) 545-553
38. Klein L., Klugmann M., Nave K.A., Tuohy V.K., and Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6 (2000) 56-61
39. Koh D.R., Fung-Leung W.P., Ho A., Gray D., Acha-Orbea H., and Mak T.W. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256 (1992) 1210-1213
40. + T cells specific for an astrocyte protein, S100 beta. J. Neural Transm., Suppl. 49 (1997) 43-51
41. Kuchroo V.K., Sobel R.A., Laning J.C., Martin C.A., Greenfield E., Dorf M.E., and Lees M.B. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. J. Immunol. 148 (1992) 3776-3782
42. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., and Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20 (2002) 101-123
43. Kumar V., and Sercarz E. Holes in the T cell repertoire to myelin basic protein owing to the absence of the D beta 2-J beta 2 gene cluster: implications for T cell receptor recognition and autoimmunity. J. Exp. Med. 179 (1994) 1637-1643
44. Lassmann H., and Ransohoff R.M. The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol. 25 (2004) 132-137
45. Lebar R., Lubetzki C., Vincent C., Lombrail P., and Boutry J.M. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin. Exp. Immunol. 66 (1986) 423-434
46. Lehmann P.V., Forsthuber T., Miller A., and Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358 (1992) 155-157
47. Lehmann P.V., Sercarz E.E., Forsthuber T., Dayan C.M., and Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14 (1993) 203-208
48. Levine S., and Sowinski R. Experimental allergic encephalomyelitis in inbred and outbred mice. J. Immunol. 110 (1973) 139-143
49. Linington C., and Lassmann H. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 17 (1987) 61-69
50. Linington C., Bradl M., Lassmann H., Brunner C., and Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130 (1988) 443-454
51. Linington C., Morgan B.P., Scolding N.J., Wilkins P., Piddlesden S., and Compston D.A. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112 Pt 4 (1989) 895-911
52. Lyons J.A., San M., Happ M.P., and Cross A.H. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29 (1999) 3432-3439
53. Maatta J.A., Kaldman M.S., Sakoda S., Salmi A.A., and Hinkkanen A.E. Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase for BALB/c and SJL mice. Immunology 95 (1998) 383-388
54. Mamula M.J., and Janeway Jr. C.A. Do B cells drive the diversification of immune responses?. Immunol. Today 14 (1993) 151-152
55. Martenson R.E., Deibler G.E., and Kies M.W. Myelin basic proteins of the rat central nervous system. Purification, encephalitogenic properties, and amino acid compositions. Biochim. Biophys. Acta 200 (1970) 353-362
56. Martin R., and McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32 (1995) 121-182
57. Martino G., and Hartung H.P. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol. 12 (1999) 309-321
58. McRae B.L., Vanderlugt C.L., Dal Canto M.C., and Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182 (1995) 75-85
59. Mendel I., Kerlero d.R., and Ben Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25 (1995) 1951-1959
60. Mendel I., Kerlero d.R., and Ben Nun A. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur. J. Immunol. 26 (1996) 2470-2479
61. Mor F., Quintana F., Mimran A., and Cohen I.R. Autoimmune encephalomyelitis and uveitis induced by T cell immunity to self beta-synuclein. J. Immunol. 170 (2003) 628-634
62. Morris-Downes M.M., McCormack K., Baker D., Sivaprasad D., Natkunarajah J., and Amor S. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 122 (2002) 20-33
63. Morris-Downes M.M., Smith P.A., Rundle J.L., Piddlesden S.J., Baker D., Pham-Dinh D., Heijmans N., and Amor S. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice. J. Neuroimmunol. 125 (2002) 114-124
64. Moudgil K.D., and Sercarz E.E. Dominant determinants in hen eggwhite lysozyme correspond to the cryptic determinants within its self-homologue, mouse lysozyme: implications in shaping of the T cell repertoire and autoimmunity. J. Exp. Med. 178 (1993) 2131-2138
65. Oliver A.R., Lyon G.M., and Ruddle N.H. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171 (2003) 462-468
66. Pal E., Tabira T., Kawano T., Taniguchi M., Miyake S., and Yamamura T. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells. J. Immunol. 166 (2001) 662-668
67. Potter N.T., and Stephens T.S. Humoral immune recognition of proteolipid protein (PLP)-specific encephalitogenic epitopes in the SJL/J mouse. J. Neurosci. Res. 37 (1994) 15-22
68. Radu C.G., Anderton S.M., Firan M., Wraith D.C., and Ward E.S. Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int. Immunol. 12 (2000) 1553-1560
69. Rauch H.C., Einstein E.R., Csejtey J., and Davis W.J. Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis. Immunochemistry 5 (1968) 567-575
70. Schmidt S. Candidate autoantigens in multiple sclerosis. Mult. Scler. 5 (1999) 147-160
71. Shastri N., Gammon G., Horvath S., Miller A., and Sercarz E.E. The choice between two distinct T cell determinants within a 23-amino acid region of lysozyme depends on their structural context. J. Immunol. 137 (1986) 911-915
72. + T-cells and beta-chemokines in the inhibition of virus infection of PBMCs in vitro. J. Med. Primatol. 30 (2001) 1-13
73. Skundric D.S., Huston K., Shaw M., Tse H.Y., and Raine C.S. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain. Lab. Invest. 71 (1994) 671-679
74. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
75. Stefferl A., Brehm U., and Linington C. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neural Transm., Suppl. (2000) 123-133
76. Steinman L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24 (1999) 511-514
77. Steinman L. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis. J. Exp. Med. 194 (2001) F27-F30
78. Steinman L. Engineering better cytokines. Nat. Biotechnol. 21 (2003) 1293-1294
79. + T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166 (2001) 7579-7587
80. Targoni O.S., and Lehmann P.V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187 (1998) 2055-2063
81. Targoni O.S., Baus J., Hofstetter H.H., Hesse M.D., Karulin A.Y., Boehm B.O., Forsthuber T.G., and Lehmann P.V. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 166 (2001) 4757-4764
82. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., and Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168 (2002) 4173-4183
83. Tuohy V.K., Sobel R.A., and Lees M.B. Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J. Immunol. 140 (1988) 1868-1873
84. Tuohy V.K., Yu M., Yin L., Kawczak J.A., and Kinkel P.R. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. J. Autoimmun. 13 (1999) 11-20
85. Urban J.L., Kumar V., Kono D.H., Gomez C., Horvath S.J., Clayton J., Ando D.G., Sercarz E.E., and Hood L. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54 (1988) 577-592
86. Van Epps H.L. Thomas Rivers and the EAE model. J. Exp. Med. 202 4 (2005) (Abstract)
87. von Budingen H.C., Tanuma N., Villoslada P., Ouallet J.C., Hauser S.L., and Genain C.P. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J. Clin. Immunol. 21 (2001) 155-170
88. Waxman F.J., Fritz R.B., and Hinrichs D.J. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis. Cell. Immunol. 49 (1980) 34-42
89. Weerth S., Berger T., Lassmann H., and Linington C. Encephalitogenic and neuritogenic T cell responses to the myelin-associated glycoprotein (MAG) in the Lewis rat. J. Neuroimmunol. 95 (1999) 157-164
90. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., and Linington C. Animal models. Ann. Neurol. 36 (1994) S47-S53 (Suppl)
91. Wilson N.S., and Villadangos J.A. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 86 (2005) 241-305
92. Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., Trezza R.P., Heinzel F.P., Forsthuber T., and Lehmann P.V. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162 (1999) 3942-3949
93. Yoshizawa I., Bronson R., Dorf M.E., and Abromson-Leeman S. T-cell responses to myelin basic protein in normal and MBP-deficient mice. J. Neuroimmunol. 84 (1998) 131-138
94. Yu M., Johnson J.M., and Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183 (1996) 1777-1788
95. Zamvil S.S., Mitchell D.J., Moore A.C., Kitamura K., Steinman L., and Rothbard J.B. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324 (1986) 258-260
96. Zamvil S.S., Mitchell D.J., Lee N.E., Moore A.C., Waldor M.K., Sakai K., Rothbard J.B., McDevitt H.O., Steinman L., and Acha-Orbea H. Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis. J. Exp. Med. 167 (1988) 1586-1596